drugset / Trial / NCT05137067

A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.

NCT05137067 ↗

Phase 2 Completed 90 enrolled Optimal Health Research
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will assess the effectiveness of a natural nutraceutical in treating the known side effects of chemotherapeutic agents in cancer patients.

Timeline

Start
2021-01-20
Primary completion
2022-10-18
Completion
2023-05-25

Drugs

EvaluationDrugModalityDoseRoute
Subject RaproCell Unknown — —
Background Cisplatin Other / unclassified — —
Background Docetaxel Small molecule — —